United States - English - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown. a

United States - English - NLM (National Library of Medicine)

exelan pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown.

United States - English - NLM (National Library of Medicine)

hevert arzneimittel gmbh & co. kg - black cohosh (unii: k73e24s6x9) (black cohosh - unii:k73e24s6x9), anamirta cocculus seed (unii: 810258w28u) (anamirta cocculus seed - unii:810258w28u), cypripedium parviflorum var. pubescens root (unii: 21y9gz1lza) (cypripedium parviflorum var. pubescens root - unii:21y9gz1lza), strychnos ignatii seed (unii: 1nm3m2487k) (strychnos ignatii seed - unii:1nm3m2487k), lilium lancifolium flowering top (unii: 6268mfa917) (lilium lancifolium flowering top - unii:6268mfa917), passiflora incarnata flowering top - black cohosh 4 [hp_x] - for temporary relief of minor symptoms of tension and stress, such as: - restlessness - mild mood changes - temporary anxiety - occasional sleeplessness these statements have not been evaluated by the food and drug administration. they are supported by traditional homeopathic principles.

United States - English - NLM (National Library of Medicine)

laboratoires boiron - black cohosh (unii: k73e24s6x9) (black cohosh - unii:k73e24s6x9), citrullus colocynthis fruit pulp (unii: 23h32aoh17) (citrullus colocynthis fruit pulp - unii:23h32aoh17), magnesium phosphate, dibasic trihydrate (unii: hf539g9l3q) (magnesium cation - unii:t6v3lhy838) - black cohosh 6 [hp_c] - temporarily relieves symptoms associated with menstrual cramps such as: discomfort, minor aches and pain do not use if glued carton en flaps are open or if the blister seal is broken cimicifuga racemosa 6c ...relieves menstrual cramps with aches and pains radiating to the thighs colcynthis 6c...relieves menstrual cramps magnesia phosphorica 6c... relieves menstrual cramps improved by warmth stop use and ask a doctor if symptoms persist for more than 7 days or worsen.

New Zealand - English - Medsafe (Medicines Safety Authority)

blackmores (nz) ltd - symphytum officinale 350 mg/g (root liquid extract, equivalent to fresh root 175 mg/g) - topical cream - 350 mg/g - active: symphytum officinale 350 mg/g (root liquid extract, equivalent to fresh root 175 mg/g) excipient: arachis oil cetostearyl alcohol glyceryl monostearate r07338 special ph fragrance lavender oil phenonip ppg-1-peg-9 lauryl glycol ether purified water siberian fir needle oil sodium hydroxide sodium laurilsulfate - indicated for short term use - up to 7 days. indicated for the temporary relief of back, joint and muscle pain, tenderness and swelling associated with soft tissue injury such as sprains, strains, contusions caused by minor injury/trauma. indicated to aid recovery by reducing symptoms of pain, swelling and stiffness. seek medical advice if symptoms persist for more than seven days. do not use for more than 3 weeks.

Australia - English - Department of Health (Therapeutic Goods Administration)

mms international health products pty ltd - black cohosh powder -

United States - English - NLM (National Library of Medicine)

avkare, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate, usp is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). - patients with hypercalcemia. patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1) ] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects

United States - English - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c: calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1 ) ]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown

United States - English - NLM (National Library of Medicine)

american health packaging - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c : calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of c

United States - English - NLM (National Library of Medicine)

avpak - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate, usp is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). - patients with hypercalcemia. patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1) ] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects